losartan has been researched along with Cytomegalovirus Infections in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Cytomegalovirus Infections: Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JA | 1 |
| Kim, JE | 1 |
| Ju, HH | 1 |
| Lee, J | 1 |
| Jee, D | 1 |
| Park, CK | 1 |
| Paik, SY | 1 |
1 other study available for losartan and Cytomegalovirus Infections
| Article | Year |
|---|---|
The effects of losartan on cytomegalovirus infection in human trabecular meshwork cells.
Topics: Actins; Connective Tissue Growth Factor; Cytomegalovirus; Cytomegalovirus Infections; Enzyme-Linked | 2019 |